Select a community
Mood Conditions including Depression, Anxiety, Bipolar, OCD, and PTSD
Find out more about the PatientsLikeMe
Mood Conditions Community
Home > Community Treatment Reports > Polyethylene Glycol 3350 Treatment Report
What is Polyethylene Glycol 3350?

Polyethylene glycol 3350 NF is an osmotic laxative used for the treatment of occasional constipation in adults.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Constipation 6 2
Other 3 0
Irritable Bowel Syndrome (IBS) 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
3 100%

Dosages

  0 as needed 17mg as needed - as needed daily 17 g daily 100 g daily 1700 g daily
  1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Polyethylene Glycol 3350 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 50% Did not seem to work: 50%

See all 1 patient who’ve stopped taking Polyethylene Glycol 3350

Duration See details about how long patients take this treatment ▼

Currently Taking Polyethylene Glycol 3350

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
1
2

Stopped Taking Polyethylene Glycol 3350

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
3 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 33%
A little
0 0%
Not at all
2 67%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
2 67%
< $25
1 33%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.